Synthesis and biological characterisation of [3H]BBL454, a new CCK2 selective radiolabelled agonist displaying original pharmacological properties

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 2, 2004, Pages 369-372

  Bellier, Bruno ^a,d   Dugave, Christophe ^b   Etivant, Frédéric ^a   Genet, Roger ^b   Gigoux, Véronique ^a   Garbay, Christiane ^a,c  

^a Laboratoire de Pharmacochimie   (France)

^b CEA SACLAY   (France)

^c CNRS   (France)

^d CENTRE D ETUDES DU BOUCHET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; TRITIUM;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHINESE HAMSTER; DRUG SYNTHESIS; GENETIC TRANSFECTION; ISOTOPE LABELING; NONHUMAN; OVARY CELL;

EID: 0346099280     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.11.001     Document Type: Article

References (20)

1. Reviewed in: Crawley J.N., Corwin R.L. Peptides. 15:1994;731.
2. Reviewed in: Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., Roques B.P. Pharmacol. Rev. 51:1999;745.
3. Reviewed in: Noble F., Roques B.P. Prog. Neurobiol. 58:1999;349.
4. Reviewed in: Daugé V., Léna I. Neurosci. Biobehav. Rev. 22:1998;815.
5. Charpentier B., Durieux C., Pélaprat D., Dor A., Reibaud M., Blanchard J.C., Roques B.P. Peptides. 9:1988;835.
6. Derrien M., McCort-Tranchepain I., Ducos B., Roques B.P., Durieux C. Pharmacol. Biochem. Behav. 49:1994;133 Charrier D., Dangoumau L., Puech A.J., Hamon M., Thiébot M.H. Psychopharmacology (Berl). 121:1995;127.
7. Ladurelle N., Roques B.P., Daugé V. J. Neurosci. 15:1995;3118.
8. Ladurelle N., Keller G., Blommaert A., Roques B.P., Daugé V. Eur. J. Neurosci. 9:1997;1804.
9. Léna I., Simon H., Roques B.P., Daugé V. Neuropharmacology. 38:1999;543.
10. Million M.E., Léna I., Danascimento S., Noble F., Daugé V., Garbay C., Roques B.P. Lett. Pept. Sci. 4:1997;407 Bellier B., Million M.E., Danascimento S., Meudal H., Kellou S., Maigret B., Garbay C. J. Med. Chem. 43:2000;3614.
11. Bellier, B. PhD Thesis, Université Paris V, 2000. Bellier, B.; Crété, D.; Million, M. E.; Beslot, F.; Bado, A.; Garbay, C.; Daugé, V. Eur. J. Pharmacol. submitted.
12. Reviewed in: Bellier B., Gigoux V., Garbay C. Curr. Med. Chem. CNSA. 1:2001;209.
13. Pommier B., Danascimento S., Dumont S., Bellier B., Million E., Garbay C., Roques B.P., Noble F. J. Neurochem. 73:1999;281.
14. Sasaki N.A., Funakoshi S., Potier P., Morgat J.L., Genet R., Gacel G., Charpentier B., Roques B.P. J. Labelled Compd. Radiopharm. 22:1985;1123.
15. Charpentier B., Roques B.P., Roy J., Morgat J.L. J. Labelled Compd. Radiopharm. 27:1989;387.
16. L'abbé G., Leurs S., Dehaen W. Tetrahedron. 49:1993;4439.
17. Osby J., Martin M.G., Ganem B. Tetrahedron Lett. 25:1984;2093.
18. 2O, 0.09% TFA), column: C18 Vydac (5 μ, 4.6 × 150 mm), 1 mL/min, λ=210 nm].
19. Gigoux V., Escrieut C., Fehrentz J.A., Poirot S., Maigret B., Moroder L., Gully D., Martinez J., Vaysse N., Fourmy D. J. Biol. Chem. 274:1999;20457.
20. 3H]pCCK-8. Results are the mean of at least three separate experiments, each performed in triplicate.